Trigeminal neuralgia and glossopharyngeal neuralgia.
Trigeminal neuralgia and glossopharyngeal neuralgia are extremely painful conditions that typically afflict an older population. Distinct clinical characteristics guide the diagnosis of these unique syndromes. Treatment involves medication first and then surgical procedures if a patient is refractory to medicinal therapy. Antiepileptic medications are the most effective agents for these disorders.
Rozen
Todd D
TD
Michigan Head-Pain and Neurological Institute, 3120 Professional Drive, Ann Arbor, MI 48104, USA. trozen@mhni.com
D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D001418:Baclofen / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D018755:GABA Agonists / Q000627:therapeutic use; D020435:Glossopharyngeal Nerve Diseases / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D006801:Humans; D010672:Phenytoin / Q000627:therapeutic use; D014277:Trigeminal Neuralgia / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery
D018712:Analgesics, Non-Narcotic; D000927:Anticonvulsants; D018755:GABA Agonists; D002220:Carbamazepine; D010672:Phenytoin; D001418:Baclofen